We are pleased to announce that the Therapeutic Radiology and Oncology (TRO) has received its 2023 CiteScore: 0.5, ranking 17 out of 20 journals in the Oncology (nursing) category.
Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.
- 39 AME journals received CiteScore this year, with two journals achieving their first CiteScore.
- 13 journals rank above average (in Q1 or Q2), with five of them positioned in the top 25% of the respective categories.
- 27 journals have witnessed an increase in their CiteScores compared to 2022.
Below are the CiteScores for all AME journals (Table 1):
Table 1 2023 CiteScore of AME journals
No. | Journal | CiteScore | Rank (Quartile) | Category |
1 | AME Medical Journal | 2.6 | 206/636 (Q2) | General Medicine |
2 | Annals of Blood | 1.6 | 102/137(Q3) | Hematology |
3 | Annals of Cardiothoracic Surgery | 4.6 | 100/551 (Q1) | Surgery |
4 | Annals of Esophagus | 0.7 | 397/551 (Q3) | Surgery |
5 | Annals of Eye Science | 1.3 | 91/137 (Q3) | Ophthalmology |
6 | Annals of Joint | 1.1 | 231/321 (Q3) | Orthopedics and Sports Medicine |
7 | Annals of Laparoscopic and Endoscopic Surgery | 1.4 | 307/551 (Q3) | Surgery |
8 | Annals of Pancreatic Cancer | 0.9 | 124/167 (Q3) | Internal Medicine |
9 | Annals of Thyroid | 0.9 | 201/244 (Q4) | Endocrinology, Diabetes and Metabolism |
10 | Australian Journal of Otolaryngology | 0.6 | 94/123 (Q4) | Otorhinolaryngology |
11 | Cardiovascular Diagnosis and Therapy | 4.9 | 124/387 (Q2) | Cardiology and Cardiovascular Medicine |
12 | Chinese Clinical Oncology | 3.9 | 212/404 (Q3) | Oncology |
13 | Digestive Medicine Research | 0.1 | 8/82 (Q4) | Hepatology |
14 | Frontiers of Oral and Maxillofacial Medicine | 0.7 | 85/123 (Q3) | Otorhinolaryngology |
15 | Gland Surgery | 3.6 | 153/551 (Q2) | Surgery |
16 | Journal of Emergency and Critical Care Medicine | 1.1 | 70/109 (Q3) | Emergency Medicine |
17 | Journal of Gastrointestinal Oncology | 3.2 | 90/167 (Q3) | Gastroenterology |
18 | Journal of Hospital Management and Health Policy | 1.2 | 226/310 (Q3) | Health Policy |
19 | Journal of Laboratory and Precision Medicine | 1.7 | 49/72 (Q3) | Biochemistry (medical) |
20 | Journal of Medical Artificial Intelligence | 2.3 | 198/398 (Q2) | Medicine (miscellaneous) |
21 | Journal of Public Health and Emergency | 1.1 | 68/109 (Q3) | Emergency Medicine |
22 | Journal of Spine Surgery | 5.6 | 58/551 (Q1) | Surgery |
23 | Journal of Thoracic Disease | 4.6 | 61/155 (Q2) | Pulmonary and Respiratory Medicine |
24 | Journal of Visualized Surgery | 0.4 | 410/511 (Q4) | Communication |
25 | Journal of Xiangya Medicine | 0.4 | 494/636 (Q4) | General Medicine |
26 | Laparoscopic Surgery | 0.8 | 378/551 (Q3) | Surgery |
27 | Mediastinum | 1.2 | 251/398 (Q3) | Medicine (miscellaneous) |
28 | mHealth | 5.4 | 167/665 (Q2) | Public Health, Environmental and Occupational Health |
29 | Pediatric Medicine | 1.2 | 217/330 (Q3) | Pediatrics, Perinatology and Child Health |
30 | Precision Cancer Medicine | 1.5 | 305/551 (Q3) | Surgery |
31 | Quantitative Imaging in Medicine and Surgery | 4.2 | 128/333 (Q2) | Radiology, Nuclear Medicine and Imaging |
32 | Shanghai Chest | 0.7 | 408/551 (Q3) | Surgery |
33 | Therapeutic Radiology and Oncology | 0.5 | 17/20 (Q4) | Oncology (nursing) |
34 | Translational Andrology and Urology | 4.1 | 40/120 (Q2) | Urology |
35 | Translational Cancer Research | 2.1 | 209/333 (Q3) | Radiology, Nuclear Medicine and Imaging |
36 | Translational Gastroenterology and Hepatology | 8.2 | 21/167 (Q1) | Gastroenterology |
37 | Translational Lung Cancer Research | 7.2 | 92/404 (Q1) | Oncology |
38 | Translational Pediatrics | 4.5 | 72/330 (Q1) | Pediatrics, Perinatology and Child Health |
39 | Video-Assisted Thoracic Surgery | 0.4 | 455/551 (Q4) | Surgery |
CiteScore is a metric launched by Elsevier in 2016 to provide comprehensive, transparent, and current insights into journal impact. The calculation of 2023 CiteScore is based on the number of citations received in 2020-2023 to 5 peer-reviewed document types (articles, reviews, conference papers, data papers, and book chapters) by a journal in the same four years, divided by the same journal’s number of peer-reviewed documents indexed in Scopus and published in those same four years. For more information on CiteScore, please visit https://service.elsevier.com/app/answers/detail/a_id/30562/supporthub/scopus/related/1/.
The CiteScores achieved reflect the valuable impact these journals have made in the scientific community. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in radiation oncology to bring more exciting content to readers in the coming future.
Editorial Office
Therapeutic Radiology and Oncology